C. Parker Gibbs Jr, MD, discusses how to test for p16 and p21 in patients with osteosarcoma.
C. Parker Gibbs
Advertisement
Articles by C. Parker Gibbs
C. Parker Gibbs Jr., MD, discusses the use of cell cycle checkpoint regulators to indicate response to treatment in osteosarcoma.
Advertisement
Latest Updated Articles
Dr. Gibbs on Predicting Response to Treatment in OsteosarcomaOctober 21st 2019
Dr. Gibbs on Testing for p16 and p21 in OsteosarcomaJanuary 22nd 2020
Advertisement
Advertisement
Trending on OncLive
1
Tam-Peli Reduces Risk of Death by 54% vs Topotecan in Relapsed SCLC
2
Ris-Rez Extends Median OS to 18.5 Months vs Topotecan in Relapsed SCLC
3
Early Discontinuation of Adjuvant Osimertinib Doubles Recurrence Risk in EGFR-Mutated NSCLC
4
Dr Felip on Sequencing Next-Generation ROS1 TKIs After Progression in NSCLC
5